EX-FILING FEES 5 ex107.htm

 

Exhibit 107

 

Calculation of Filing Fee Table

 

Form S-1

(Form Type)

 

Serina Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

  

Security

Type

  Security Class Title 

Fee

Calculation

or Carry

Forward

Rule

  Amount Registered(1)  

Proposed

Maximum

Offering

Price Per

Unit

  

Maximum

Aggregate

Offering

Price

   Fee Rate  

Amount of

Registration

Fee

 
Newly Registered Securities
Fees
to be Paid
  Equity  Common stock underlying the Post-Merger Warrants  457(g)   1,500,284   $13.20(2)  $  19,803,748.80    0.00014760   $2,923.03 
Fees
to be Paid
  Equity  Common stock underlying the Incentive Warrants  457(g)   1,500,284   $18.00(3)  $27,005,112.00    0.00014760   $3,985.95 
Fees
to be Paid
  Equity  Common stock  457(c)   1,889,323   $8.73(4)  $16,493,789.80    0.00014760   $2,434.48 
Fees
to be Paid
  Equity  Incentive Warrants to purchase common stock  457(g)   1,500,284    (5)    -    -    - 
Carry Forward Securities
-  -  -  -   -    -    -    -    - 
   Total Offering Amounts   $63,302,650.60        $9,343.46 
   Total Fees Previously Paid             $- 
   Total Fee Offsets             $- 
   Net Fee Due             $9,343.46 

 

(1)Includes an indeterminable number of additional securities that, pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), may be issued by reason of any stock split, stock dividend or similar transaction.
(2)Calculated pursuant to Rule 457(g) under the Securities Act, based on the $13.20 exercise price per share of common stock issuable upon exercise of the Post-Merger Warrants.
(3)Calculated pursuant to Rule 457(g) under the Securities Act, based on the $18.00 exercise price per share of common stock issuable upon exercise of the Incentive Warrants.
(4)Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the common stock on the NYSE American on April 29, 2024 ($8.73 per share of common stock). This calculation is in accordance with Rule 457(c) of the Securities Act.
(5)Pursuant to Rule 457(g) of the Securities Act, no separate fee is recorded for the Incentive Warrants, as the entire fee is allocated to the underlying common stock.